Records containing: Pancreas Adenocarcinoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2025-04-16
A Phase II Open-Label Study of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced, Recurrent, or Metastatic Pancreatic Adenocarcinoma (EPIC)
CLINICAL_TRIALS study record update · 2025-03-20
Diagnostic Value of Diffusion-weighted Magnetic Resonance Imaging for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma: a Pilot Study.
CLINICAL_TRIALS study record update · 2025-02-13
Phase II Clinical Study on Resectable or Borderline Resectable Pancreas Adenocarcinoma Preoperative Treatment with Chemotherapy and Carbon Ions Radiation Therapy (hadrontherapy)
CLINICAL_TRIALS study record update · 2024-11-15
A Phase I Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Patients with Solid Tumors
CLINICAL_TRIALS study record update · 2024-10-04
Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoa: Should it be Performed? A Multicentre Randomized Controlled Trial.
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2024-08-15
CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)
CLINICAL_TRIALS study record update · 2024-07-12
The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer.
CLINICAL_TRIALS study record update · 2024-06-24
Intraoperative Near-infrared Fluorescence Imaging in Pancreatic- and Extrahepatic Bile Duct Tumors Using cRGD-ZW800-1 and Dedicated Imaging Systems: A Phase II Feasibility Testing, Dose-ranging and Optimal Dose-(Interval) Selection Trial
CLINICAL_TRIALS study record update · 2024-04-16
Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX: a Prospective, Pilot Study
CLINICAL_TRIALS study record update · 2024-04-04
A Performance Study of SGM-101, a Fluorochrome-labeled Anti-carcinoembryonic Antigen Monoclonal Antibody for Fluorescence-guided Imaging to Determine Local Extent and Resectability During Surgical Resection of Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment
CLINICAL_TRIALS study record update · 2024-03-18
Digital Confocal Microscopy for Real-time Diagnosis of Pancreatic Solid Lesion: a Multicentre Study
CLINICAL_TRIALS study record update · 2024-02-26
A Study Using 18F-FAPI PET to Evaluate Pathologic Response to Systemic Treatment in Pancreatic Adenocarcinoma
CLINICAL_TRIALS study record update · 2024-02-20
A Proof-of-Concept Study Evaluating LINFU™: A Noninvasive Method for Increasing Exfoliation of Pancreatic Ductal Cells Into the Pancreatic Fluid for the Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC)
CLINICAL_TRIALS study record update · 2024-02-16
PRECISE: PancREatic Cancer and Individualised Supervised Exercise: a Feasibility Study
CLINICAL_TRIALS study record update · 2023-12-07
Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis: A 3 Cohorts Case Control Matched Study
CLINICAL_TRIALS study record update · 2023-10-19
A Phase 1b/2Study of Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss (MANTRA-4)
CLINICAL_TRIALS study record update · 2023-10-04
Prevalence and Consequences of Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer: a Prospective Population Based Multicenter Study. The PALN Study
CLINICAL_TRIALS study record update · 2023-09-26
Improving Pancreatic Cancer Care by the Use of Computational Science and Technology
CLINICAL_TRIALS study record update · 2023-08-25
Prospective Observational Study of Prevalence, Assessment and Treatment of Pancreatic Insufficiency in Patients With Pancreatic Malignancies
CLINICAL_TRIALS study record update · 2023-06-01
18F-FAPI PET/CT and 18F-FDG PET/CT in Patients With Pancreatic Adenocarcinoma : A Prospective, Single-Center, Comparative Study
CLINICAL_TRIALS study record update · 2023-04-19
New Onset of DiabetEs in aSsociation With Pancreatic Cancer
CLINICAL_TRIALS study record update · 2023-03-31
Safety and Efficacy of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma: Open Label Prospective Randomized Clinical Trial
CLINICAL_TRIALS study record update · 2022-12-27
A SU2C Catalyst ® Randomized Phase II Trial of the PD1 Inhibitor Pembrolizumab With or Without a Vitamin D Receptor Agonist Paricalcitol in Patients With Stage IV Pancreatic Cancer Who Have Been Placed in Best Possible Response
CLINICAL_TRIALS study record update · 2022-12-06
The βIG-H3 Protein: a New Marker in PANCreatic Adenocarcinoma
CLINICAL_TRIALS study record update · 2022-11-30
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer - a Multicenter Prospective Observational Study